Research Topics
Species | David NelsonSummaryAffiliation: University of Florida Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cellsLuyu Yao
Division of Gastroenterology and Hepatology, Department of Medicine, University of Florida Jacksonville, FL 32206, USA
Virol J 8:445. 2011..5-IRF3ER cells. The results of this study indicate that IRF-3ER homodimerization is a key step to restore IFN expression in Huh7.5-IRF3ER cells and in achieving its anti-HCV effects...
Pathogenesis of chronic hepatitis C virus infectionD R Nelson
Department of Medicine, University of Florida, Gainesville, USA
Antivir Ther 3:25-35. 1998..A better understanding of the host's immune response may provide further insight on the pathogenetic mechanisms involved in development of chronic hepatitis and aid the development of better therapeutic strategies...
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson
University of Florida, Gainesville, Florida, USA
Gastroenterology 139:1267-76. 2010....
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis CDavid R Nelson
University of Florida College of Medicine, Box 100214, Room M 440, Gainesville, Florida 32610 0214, USA
Clin Gastroenterol Hepatol 7:212-8. 2009..This phase 2 study evaluated the safety/efficacy of albinterferon in CHC patients who had not responded to interferon-based regimens...
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effectDavid R Nelson
Department of Medicine, University of Florida, 1600 S W Archer Road, PO Box 100214, Gainesville, FL 32610 0214, USA
Hepatology 38:859-68. 2003..In conclusion, long-term rIL-10 therapy appears to decrease disease activity, but also leads to increased HCV viral burden via alterations in immunologic viral surveillance...
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patientsDavid R Nelson
Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainsville, USA
Ann Hepatol 11:15-31. 2012..This phase 2, double-blind international trial evaluated the optimal treatment regimen of balapiravir plus peginterferon alfa-2a (40KD)/ribavirin...
Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationD R Nelson
Center for Liver Transplantation and Hepatobiliary Diseases, University of Florida, Gainesville, FL 32610, USA
Liver Transpl 7:1064-70. 2001....
The immunopathogenesis of hepatitis C virus infectionD R Nelson
Section of Hepatobiliary Diseases, Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, USA
Clin Liver Dis 5:931-53. 2001..A better understanding of the host's immune response may provide further insight on the pathogenetic mechanisms involved in development of chronic hepatitis and aid the development of better therapeutic strategies...
Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonrespondersD R Nelson
Section of Hepatobiliary Diseases and Department of Pathology, University of Florida College of Medicine, Gainesville, Florida, USA
Gastroenterology 118:655-60. 2000..The aim of this study was to determine the effect of IL-10 on hepatic injury in patients with chronic hepatitis C...
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis CRoberto J Firpi
Department of Medicine, Section of Hepatobiliary Diseases, University of Florida, Gainesville, FL 32610, USA
Liver Transpl 8:1000-6. 2002..In summary, combination therapy is a reasonable antiviral option for recurrent HCV infection for established post-LT hepatitis and appears to prevent histological progression of disease if viral eradication is successful...
Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell lineHaizhen Zhu
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville 32610, USA
Hepatology 37:1180-8. 2003..Our results also suggest that IFN-alpha-induced target genes may play an important role in IFN-alpha anti-HCV activity...
Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantationRoniel Cabrera
Department of Medicine, Division of Gastroenterology, Hepatology Section of Hepatobiliary Diseases and Liver Transplantation, University of Florida, Gainesville, USA
Am J Clin Oncol 35:345-50. 2012..To evaluate the impact of long-term outcomes of transarterial embolization (TAE) therapy in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) on the waiting list for liver transplantation (LT)...
Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantationScott J Weston
Department of Medicine, Oregon Health and Science University, USA
Hepatology 41:72-81. 2005..Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience. wiley.com/jpages/0270-9139/suppmat/index.html)...
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 studyRobert G Gish
Department of Medicine, Division of Hepatology and Complex GI, Physicians Foundation, California Pacific Medical Center, San Francisco, CA, USA
J Hepatol 47:51-9. 2007..Taribavirin, a ribavirin prodrug, has shown a lower incidence of anemia. We sought to determine the efficacy and safety of taribavirin vs. ribavirin combined with pegylated interferon in patients with chronic hepatitis C (CHC)...
Different radiosensitivity of CD4(+)CD25(+) regulatory T cells and effector T cells to low dose gamma irradiation in vitroMengde Cao
Section of Hepatobiliary Diseases, Department of Medicine, University of Florida, Gainesville, FL 32610 0214, USA
Int J Radiat Biol 87:71-80. 2011..To determine the radiosensitivity difference of human Cluster of Differentiation (CD)4(+)CD25(+) regulatory T cells (Treg) and effector T cells to low dose gamma ray and elucidate the underlying mechanisms in vitro...
Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patientsRoniel Cabrera
Hepatobiliary Section, Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Florida, Gainesville, FL 32610, USA
Liver Transpl 15:216-22. 2009..In conclusion, these data show the potential utility of the ImmuKnow assay as a means of distinguishing hepatitis C from cellular rejection and its potential usefulness as a marker for outlining the progression of hepatitis C...
Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistanceHaizhen Zhu
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, 32610, USA
J Interferon Cytokine Res 25:528-39. 2005..Our study implies that long-term IFN stimulation in vitro selects cells that exhibit alterations in the host Jak-Stat signaling pathway, thereby representing a potential mechanism by which HCV resists IFN therapy...
Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense systemHaizhen Zhu
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
Gastroenterology 133:1649-59. 2007..However, the interaction between HCV and hepatocyte innate antiviral defense systems is not understood. The aim of this study was to examine how human hepatocytes respond to HCV infection...
Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomasShiro Fujita
Department of Surgery, College of Medicine, University of Florida, Gainesville, Florida 32610 0286, USA
J Gastroenterol Hepatol 21:1351-4. 2006..We show three cases without recurrent lesions detected in follow-up examination. Two of the patients have subsequently gone on to carry pregnancies successfully to term...
Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosisCynthia Levy
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida 32608, USA
Clin Gastroenterol Hepatol 5:803-8. 2007..We aimed to determine the prevalence of esophageal varices in patients with PBC, to evaluate noninvasive markers of esophageal varices in this population, and to validate the results in an independent set of patients...
Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?Shiro Fujita
Division of Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, FL 32610 0286, USA
Transplantation 84:1631-5. 2007..The aim of the current study is to determine if recurrence of hepatitis C affects biliary complications after LT, with special reference to late biliary anastomotic strictures (LBAS)...
Novel interferons for treatment of hepatitis C virusVirginia Clark
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Florida, Gainesville, FL 32610, USA
Clin Liver Dis 13:351-63. 2009..This review highlights novel interferons under development that may offer therapeutic advantages over the formulations currently available...
Short recovery time after percutaneous liver biopsy: should we change our current practices?Roberto J Firpi
Division of Gastroenterology, Hepatology and Nutrition Section of Hepatobiliary Diseases, University of Florida, 1600 SW Archer Road, PO Box 100214, Gainesville, FL 32610 0214, USA
Clin Gastroenterol Hepatol 3:926-9. 2005..The aim of this study was to determine whether ambulatory patients requiring percutaneous liver biopsy can be safely discharged after a short recovery time period...
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantationRoberto J Firpi
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Section of Hepatobiliary Diseases, University of Florida, Gainesville, FL 32610 0214, USA
Liver Transpl 12:51-7. 2006..In conclusion, Cyclosporine may offer an advantage to Tacrolimus in those patients undergoing interferon-based therapy and should be studied in a prospective randomized trial...
Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosisGiuseppe Morelli
Division of Gastroenterology and Hepatology and Nutrition Section of Biliary Diseases and Liver Transplantation, University of Florida, Gainesville, FL 32610-0214, USA
Liver Transpl 12:306-9. 2006
The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naïve patientsDavid R Nelson
Clinical and Translational Science Institute, University of Florida, FL 32610, USA
Liver Int 31:53-7. 2011..However, these dramatic gains will be partially offset by new challenges in viral resistance and increased adverse events...
The natural history of hepatitis C cirrhosis after liver transplantationRoberto J Firpi
Section of Hepatobiliary Diseases, Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, FL 32610 0214, USA
Liver Transpl 15:1063-71. 2009..The Model for End-Stage Liver Disease can stratify risk for decompensation and survival, whereas successful antiviral therapy may be protective...
Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantationVictor I Machicao
Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, FL 32610-0214, USA
Liver Transpl 12:754-61. 2006..In conclusion, the implementation of the MELD allocation system is not associated with increased mortality or occurrence of CRD-3 or CRD-4 in the first 2 years after LT...
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot studyRoberto J Firpi
Division of Gastroenterology, Hepatology and Nutrition, Section of Hepatobiliary Diseases and Liver Transplantation, Department of Medicine, University of Florida, Gainesville, FL 32610 0214, USA
Dig Dis Sci 55:196-203. 2010..We performed a pilot study to prospectively determine the antiviral effect of cyclosporine during therapy with PEGalfa-2a and ribavirin in liver transplant recipients with recurrent HCV infection...
Management of viral hepatitis in hematologic malignanciesRoberto J Firpi
Division of Gastroenterology, Hepatology and Nutrition Section of Hepatobiliary Diseases and Liver Transplantation, University of Florida Gainesville, FL 32610 0214, USA
Blood Rev 22:117-26. 2008..In this review we will highlight the mechanisms of virus reactivation, clinical manifestations, and management strategies to minimize acute and chronic morbidity in this population...
Current and future hepatitis C therapiesRoberto J Firpi
Section of Hepatobiliary Diseases and Liver Transplantation, Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida 32610 0214, USA
Arch Med Res 38:678-90. 2007..This review will focus on current therapies for hepatitis C and the most recent advances in the search for new therapies...
Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25)Roniel Cabrera
Section of Hepatobiliary Diseases, Department of Medicine, University of Florida, 1600 SW Archer Rd, PO Box 100214, Gainesville, FL 32610 0214, USA
Dig Dis Sci 55:484-95. 2010..The mechanisms involved in hepatocellular carcinoma (HCC) establishing an immunologically tolerogenic tumor environment remain poorly characterized...
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replicationHaizhen Zhu
Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida 32610, USA
Virol J 2:80. 2005..The effectiveness of IL-28A antiviral activity and its synergistic effect on IFN-alpha indicate that IL-28A may be potentially used to treat HCV chronic infection...
Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infectionRoberto J Firpi
Section of Hepatobiliary Diseases, Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, PO Box 100214, JHMHC, Gainesville, FL 32610 0214, USA
Liver Transpl 9:57-61. 2003..The most common side effects were headache, nausea, and diarrhea. Mycophenolate alone does not appear to have a significant antiviral or biochemical effect in patients with chronic hepatitis C...
Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and researchShawna L Ehlers
Department of Clinical and Health Psychology, University of Florida Health Science Center, Gainesville FL 32610 0165, USA
Liver Transpl 10:412-7. 2004....
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infectionRoberto J Firpi
Division of Gastroenterology, Hepatology, and Nutrition Section of Hepatobiliary Diseases, University of Florida, Gainesville, FL 32610 0214, USA
Liver Transpl 10:1240-7. 2004..A liver biopsy performed at 1 year posttransplant can help identify those patients more likely to develop progressive disease and may allow better targeting of antiviral therapy...
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis CManal F Abdelmalek
Department of Medicine, Section of Hepatobiliary Diseases University of Florida, Gainesville, FL 32610 0214, USA
Liver Transpl 10:199-207. 2004..05). In conclusion, loss of HCV after treatment of recurrent chronic hepatitis C with interferon and ribavirin is durable, and the durability of the SVR is associated with improvement in hepatic inflammation and regression of fibrosis...
Iron regulator hepcidin exhibits antiviral activity against hepatitis C virusHongyan Liu
Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, United States of America
PLoS ONE 7:e46631. 2012..In conclusion, hepcidin can induce intracellular antiviral state while HCV has a strategy to suppress hepcidin expression. This may be a novel mechanism by which HCV circumvents hepatic innate antiviral defense...
Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cellsMengde Cao
Section of Hepatobiliary Diseases, Department of Medicine, University of Florida, Gainesville, FL 32610 0214, USA
Cell Biol Int 33:565-71. 2009..Our findings suggest that radiotherapy may be an important strategy to alter the immunologic balance of Tregs and effector cells in cancer therapy...
Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver diseaseDiana M Toivola
Department of Medicine, Palo Alto VA Medical Center, Stanford University School of Medicine Digestive Disease Center, Palo Alto, CA 94304, USA
Hepatology 40:459-66. 2004..In conclusion, site-specific keratin phosphorylation in liver disease is a progression marker when increased and a likely regression marker when decreased...
Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cellsMengde Cao
Section of Hepatobiliary Diseases, Department of Medicine, University of Florida, Gainesville, FL 32610 0214, USA
Lab Invest 87:582-90. 2007..In conclusion, these results strongly suggest that tumor-related factors not only induce and expand CD4(+)CD25(+) cells, but also enhance their suppressor ability...
CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activityChen Liu
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL, USA
Hepatology 37:1335-42. 2003..This T-cell/HCV subgenomic replicon system represents a model for the investigation of CD8 cell interaction with HCV-infected hepatocytes...
Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical centerJen Jung Pan
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, 1600 Southwest Archer Road, Room M 440, Gainesville, FL 32610, USA
J Vasc Interv Radiol 19:1576-81. 2008..This retrospective analysis was conducted to identify factors predictive of survival after transjugular intrahepatic portosystemic shunt (TIPS) creation...
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis CKeyur Patel
Division of Gastroenterology, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
Clin Gastroenterol Hepatol 6:242-7. 2008..We hypothesized that a noninvasive test of liver fibrosis can accurately stage liver fibrosis. We prospectively evaluated the FIBROSpect II (FSII) biomarker panel versus pathology assessment and a quantitative measure of fibrosis...
Mortality following operations for lower extremity peripheral arterial diseaseTracie C Collins
Department of Medicine, Division of General Internal Medicine, University of Minnesota, Minneapolis, MN 55455, USA
Vasc Health Risk Manag 6:287-96. 2010..We sought to identify risk factors associated with mortality following surgery for peripheral arterial disease (PAD)...
An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infectionRoniel Cabrera
Section of Hepatobiliary Diseases, Department of Medicine, University of Florida, Gainesville, FL 32610-0214, USA
Hepatology 40:1062-71. 2004..In conclusion, CD4(+)CD25(+) T lymphocytes constitute a highly differentiated population and appear to play a role in viral persistence by suppressing HCV-specific T cell responses in a cell-cell contact manner...
Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosisXian Zhang Shang
Department of Pathology, Immunology and Laboratory Medicine, University of Florida, P O Box 100275, Gainesville, FL 32610, USA
Lab Invest 84:332-41. 2004..Our study suggests that mutant beta-catenin can promote cell proliferation and cell survival ability, but the stabilized beta-catenin alone is insufficient for completely oncogenic transformation...
New therapies in the management of hepatitis C virusAnthony J Michaels
Division of Hepatology and Liver Transplantation, Shands Hospital, University of Florida, Gainesville, Florida, USA
Curr Opin Gastroenterol 26:196-201. 2010..This article will discuss the most promising up-to-date hepatitis C virus antiviral therapies in clinical investigation as well as the associated clinical trial results...
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcomeAndrew F Shorr
Department of Medicine, Section of Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington, DC, USA
Crit Care 10:R92. 2006..The objective of this study was to determine whether early directional changes in protein C levels correlate with outcome...
A brief psychological intervention to improve adherence following transplantationGail L Lisson
Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610-0165, USA
Ann Transplant 10:52-7. 2005..This intervention has been very favorably received by patients, caregivers, transplant physicians, and nurse coordinators...
Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver diseaseManal F Abdelmalek
Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida, USA
Clin Gastroenterol Hepatol 4:1162-9. 2006..An association between nonalcoholic fatty liver disease (NAFLD) and the insulin resistance (IR) syndrome exists. Familial clustering of IR may support a genetic predisposition to NAFLD or cryptogenic cirrhosis (CC)...
Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated)Andrew F Shorr
Department of Medicine, Section of Pulmonary and Critical Care Medicine, Washington Hospital Center, Irving Street, Washington, District of Columbia 20010, USA
Crit Care 12:R45. 2008..The goal of this study was to identify a dependable, sensitive measure with which to monitor disease progression and response in patients during DrotAA treatment...
Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantationKarim Samara
Department of Internal Medicine, University of Florida, Gainesville, Florida 32608-0214, USA
Dig Dis Sci 51:1226-9. 2006
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipientsGary L Davis
Division of Hepatology, Baylor University Medical Center, Dallas, TX 75246, USA
Liver Transpl 11:941-9. 2005..Further studies are required to determine whether the drug has beneficial effects in this group of patients...
Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?Stefan Zeuzem
JW Goethe University Hospital, Frankfurt, Germany
Antivir Ther 13:747-60. 2008..The treatment paradigm for chronic hepatitis C continues to evolve and will eventually incorporate new drugs as they are approved...
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried
University of North Carolina, Chapel Hill, NC 27514, USA
Hepatology 48:1033-43. 2008....
The financial burden of transplantation: a single-center survey of liver and kidney transplant recipientsJames R Rodrigue
The Transplant Center and the Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Transplantation 84:295-300. 2007..These findings highlight the potential financial impact of transplantation on patients and families, and they have implications for assisting patients in managing out-of-pocket expenses after transplantation...
Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsisWilliam L Macias
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
Crit Care Med 32:2385-91. 2004..Diligence by coordinating centers, site investigators, study coordinators, and sponsors is necessary to ensure that the protocol is executed as designed such that a treatment benefit, if present, will be evident...
Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICUThomas R Gildea
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, 9500 Euclid Ave, G62, Cleveland, OH 44195, USA
Chest 126:1598-603. 2004....
International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTHAndreas Sashegyi
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
Curr Med Res Opin 22:1001-12. 2006....
Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trialPierre-Francois Laterre
Department of Critical Care, St Luc University Hospital, UCL, Brussels, Belgium
Crit Care Med 32:2207-18. 2004..Additional survivors created with DrotAA treatment did not increase per-patient resource use or intensive care unit or hospital length of stay...
Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis CVijayan Balan
Mayo Clinic, Phoenix, AZ, USA
Antivir Ther 11:901-8. 2006..05). In conclusion, alb-IFN demonstrated robust induction of ISG that was consistent with the response associated with an IFN-alpha...
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis CMark W Russo
Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease and University of North Carolina at Chapel Hill, NC 27599 7080, USA
Liver Transpl 11:1235-41. 2005..004). In conclusion, hepatic stellate cell activation early after liver transplantation complements traditional testing for identifying liver transplant recipients with hepatitis C at greatest risk for developing advanced fibrosis...
Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsisLakhmir S Chawla
Department of Anesthesiology and Critical Care Medicine, The George Washington University Medical Center, Washington, DC 20037, USA
Clin J Am Soc Nephrol 2:22-30. 2007..IL-6 data and the absence of correlation with measures of hypotension (e.g., mean arterial pressure, dosage of vasopressors) support the notion that inflammation is a significant component of AKI in SS...
C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective studyCarlos A Labarrere
Methodist Research Institute, Clarian Health Partners, Methodist, Indiana University, Riley Hospitals, Indianapolis, IN 46202, USA
Lancet 360:1462-7. 2002..We investigated whether C-reactive protein, known to stimulate ICAM-1, was associated with increased ICAM-1 concentration and subsequent development of coronary artery disease...
Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective studyRamadan A Saleh
Center for Advanced Research in Human Reproduction, Infertility, and Sexual Function, Urological Institute, The Cleveland Clinic Foundation, Ohio 44195, USA
Fertil Steril 78:491-9. 2002..Given the potential adverse effects of seminal OS on fertility, physicians should advise infertile men who smoke cigarettes to quit...
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failureJean Francois Dhainaut
Department of Intensive Care, Cochin Hospital, AP HP, Cochin Institute, Cochin Port Royal Medical School, Paris V University, Paris, France
Crit Care Med 33:341-8. 2005..To determine whether changes in coagulation biomarkers during the first day of severe sepsis correlate with progression from single to multiple organ failure and subsequent death...
Underlying disorders and their impact on the host response to infectionJean Francois Dhainaut
Intensive Care and Emergency Department, Cochin University Hospital, Rene Descartes University, Paris, France
Clin Infect Dis 41:S481-9. 2005..Although innate immunity seems not to be actually blunted in patients with underlying disorders, the underlying disorder itself contributes to the severity of the physiological response to sepsis, thereby resulting in a worse outcome...
Peritoneal fluid leptin is associated with chronic pelvic pain but not infertility in endometriosis patientsMohamed A Bedaiwy
Center for Advanced Research in Human Reproduction, Infertility, and Sexual Function, Department of Obstetrics Gynecology, Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Hum Reprod 21:788-91. 2006..The objective of this study was to evaluate the peritoneal fluid levels of leptin in patients with endometriosis and idiopathic infertility and compare them with a control group of tubal ligation/reanastomosis patients...
Interleukin-10 inhibition of nitric oxide biosynthesis involves suppression of CAT-2 transcriptionChun Jen Huang
Department of Anesthesiology, Mackay Memorial Hospital
Nitric Oxide 6:79-84. 2002..Moreover, our data suggests that transcriptional control of CAT-2 plays a role in IL-10 mediated influences upon nitric oxide biosynthesis...
Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsisWilliam L Macias
Lilly Research Laboratories, Indianapolis, Indiana, USA
Crit Care 9:R607-22. 2005..Such an interaction might warrant a change in the assumptions that underlie current trial designs...
Non-immunologic vascular failure of the transplanted heartCarlos A Labarrere
Methodist Research Institute, Clarian Health Partners (Methodist, Indiana University and Riley Hospitals, Indianapolis, Indiana 46202, USA
J Heart Lung Transplant 22:236-40. 2003
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)Steven M Opal
Brown University School of Medicine, Providence, RI, USA
Clin Infect Dis 37:50-8. 2003..Results demonstrate that DrotAA, administered as an adjunct to standard anti-infective therapy, can improve the rate of survival for patients who develop severe sepsis regardless of causative microorganism...
Severe protein C deficiency predicts early death in severe sepsisWilliam L Macias
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
Crit Care Med 32:S223-8. 2004..To explore the relationship between measures of baseline disease severity and survival time in patients with severe sepsis...
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safetyPierre Francois Laterre
Department of Critical Care Medicine, Hôpital St Luc, Universite Catholique de Louvain, B 1200 Brussels, Belgium
J Crit Care 22:142-52. 2007..Initial analyses evaluated the 28-day survival in the placebo group and further assessed the treatment effect of drotrecogin alfa (activated) (DrotAA)...
The protein C pathway: implications for the design of the RESPOND studyBurkhard Vangerow
Eli Lilly Critical Care Europe, Air Center, 1214 Vernier Geneva, Switzerland
Crit Care 11:S4. 2007....
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan
Mayo Clinic, Phoenix, AZ, USA
Antivir Ther 11:35-45. 2006..These results support further clinical studies of albumin-IFN-alpha for the treatment of patients with chronic hepatitis C...
Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein CS Betty Yan
Lilly Research Laboratories, Indianapolis, IN, USA
Crit Care Med 32:S239-46. 2004....
Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of deathMark D Williams
Crit Care 10:424. 2006
Hepatic mucormycosis in a renal transplant recipientKristin L Mekeel
Transplantation 79:1636. 2005
Effects of drotrecogin alfa (activated) in human endotoxemiaAndre C Kalil
UMDNJ-Robert Wood Johnson Medical School, Department of Surgery, New Brunswick, New Jersey 08903, USA
Shock 21:222-9. 2004..These results suggest a novel role for drotrecogin alfa (activated) in the human endotoxin model...
Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated databaseDidier Payen
Surgery 142:426-7. 2007
Sexual dysfunction in men undergoing infertility evaluation: a cohort observational studyRamadan A Saleh
Center for Advanced Research in Human Reproduction, Infertility, and Sexual Function, Urological Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Fertil Steril 79:909-12. 2003..CONCLUSION(S): Our study indicates that some men may experience sexual dysfunction of a psychogenic nature in response to the diagnosis of infertility...
Research Grants
- CELLULAR IMMUNE RESPONSE IN CHRONIC HEPATITIS CDavid Nelson; Fiscal Year: 2003..These studies will provide insight into basic immunologic principles associated with the host's immune response to this viral infection, as well as provide the basis for new interventional strategies. ..
- Basic & Clinical Research Training in Gastroenterology and HepatologyDavid Nelson; Fiscal Year: 2007..Since 2002 the Gl Division has trained 21 Gl fellows, with 12 still in training. Of these 21 individuals, 2 are African American (10%), 2 are Hispanic (10%), and 7 are women (33%). ..
- Mechanisms of Innate and Adaptive Immunity In HCVDavid Nelson; Fiscal Year: 2009..A better understanding of the immunologic factors that determine resolution or persistence of the infection may help in the design of therapies and vaccines for the control of HCV infection. ..
